PBM reform: The challenges of PrEP access

Managed Healthcare Executive
January 24, 2025

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.

Pin It on Pinterest

HIV+Hepatitis Policy Institute
Share This